Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · SHOULDER INNOVATIONS, INC. (SI)

Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer

Neutral Impact 2 of 5 leadership Written later

Shoulder Innovations announced that Jon Osborne, previously Vice President of Commercial Development, was promoted to Chief Commercial Officer effective August 6, 2026. He will oversee the company's entire commercial organization, which the company says is central to scaling adoption of its shoulder implant portfolio. The filing contains no financial results or guidance.

Key points

  • Jon Osborne promoted to Chief Commercial Officer, effective August 6, 2026
  • Osborne joined the company as Vice President of Commercial Development in September 2023
  • Previously held roles at Smith & Nephew Inc. from 2014 to 2023 and at ArthroCare, Tornier USA and Team Surgical from 1998 to 2014
  • Announced in a press release furnished as Exhibit 99.1 under Regulation FD

The filing

CompanySHOULDER INNOVATIONS, INC. (SI)
Form8-K, current report
Filed with the SECAug 10, 2026, 7:09 AM ET
Accession number0001699350-26-000054

Items reported: 7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:53 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 10, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.